NDC 86032-051 - Lomustine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 86032-051
- Package NDCs from labels
- 86032-051-01
- Manufacturer
- Evereen Shanghai Biotechnology Ltd. | Newstarpharm Technology Limited
- Effective date
- 2025-06-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lomustine | Evereen Shanghai Biotechnology Ltd. | Newstarpharm Technology Limited | 2025-06-04 | BULK INGREDIENT - ANIMAL DRUG |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 86032-051-01 | Lomustine | 25 g in 1 BAG | POWDER | 25 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lomustine | LOMUSTINE | Wilshire Pharmaceuticals, Inc. | 3c3637fc-4499-4331-a3c4-6969fc86704e | 2026-02-12 | Boxed warning, Warnings, Adverse reactions | 7BRF0Z81KG |
| LOMUSTINE | LOMUSTINE | Carnegie Pharmaceuticals LLC | 916dfac8-da11-40e4-9e44-a909e29a6b5f | 2025-10-28 | Boxed warning, Warnings, Adverse reactions | 7BRF0Z81KG |
| Gleostine | LOMUSTINE | Azurity Pharmaceuticals, Inc. | 3529fe2f-3c23-4862-bb20-b48026957082 | 2025-09-25 | Boxed warning, Warnings, Adverse reactions | 7BRF0Z81KG |
| Gleostine | LOMUSTINE | NextSource Biotechnology, LLC | 7f77526b-4c40-409c-82ea-d0f934d89cc2 | 2024-01-23 | Boxed warning, Warnings, Adverse reactions | 7BRF0Z81KG |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.